share_log

Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket

Benzinga Real-time News ·  Jan 6, 2023 08:03

Gainers

  • OncoCyte Corporation(NASDAQ:OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products that address larger markets.
  • Spruce Biosciences, Inc.(NASDAQ:SPRB) shares rose 84% to $2.30 in pre-market trading. Spruce Biosciences and Kaken Pharmaceutical reported an exclusive licensing agreement to develop and commercialize Tildacerfont for CAH in Japan.
  • CytomX Therapeutics, Inc.(NASDAQ:CTMX) rose 70.4% to $3.05 in pre-market trading. CytomX and Moderna reported a strategic research collaboration for mRNA-based conditionally activated therapeutics.
  • AMTD Digital Inc. (NYSE:HKD) shares rose 40.2% to $42.00 in pre-market trading...
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment